dipyridamole has been researched along with Cardiac Toxicity in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Doxorubicin caused cardiotoxicity as indicated by a significant increase in tumor necrosis factor-α, interleukin-6, malondialdehyde, and caspase-3 level (P<0." | 8.12 | Dipyridamole ameliorates doxorubicin-induced cardiotoxicity. ( Alyasiry, E; Hadi, N; Janabi, A, 2022) |
| " Doxorubicin caused cardiotoxicity as indicated by a significant increase in tumor necrosis factor-α, interleukin-6, malondialdehyde, and caspase-3 level (P<0." | 4.12 | Dipyridamole ameliorates doxorubicin-induced cardiotoxicity. ( Alyasiry, E; Hadi, N; Janabi, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alyasiry, E | 3 |
| Janabi, A | 3 |
| Hadi, N | 3 |
| MARINO, A | 1 |
2 other studies available for dipyridamole and Cardiac Toxicity
| Article | Year |
|---|---|
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin | 2022 |
INFLUENCE OF PSYCHOLOGICAL STRESS ON THE SPECIFIC CARDIOTOXICITY OF DRUGS.
Topics: Angiotensins; Antihypertensive Agents; Carbamates; Cardiotoxicity; Dipyridamole; Electrocardiography | 1964 |